Genetics Played Role in Rare Blood Clots Linked to COVID-19 Vaccines, Researchers Find
Rare but deadly blood clots tied to Johnson & Johnson and AstraZeneca Plc’s Covid-19 shots were caused by an autoimmune reaction that some people are predisposed to, researchers found, a discovery that they say will shape development of future vaccines.
[time-brightcove not-tgx=”true”]
Adenovirus-based vaccines, like the J&J and AstraZeneca shots that were later pulled from the market, contain a component that, in genetically susceptible people, can trigger the production of unusually structured antibodies against a protein involved in blood clotting, scientists said Wednesday in a letter to t...
Source: TIME: Health - May 16, 2024 Category: Consumer Health News Authors: Jason Gale / Bloomberg Tags: Uncategorized COVID-19 News Desk overnight wire Source Type: news
Varian to distribute Innova's thrombectomy system
Siemens Healthineers company Varian will distribute medical device company Innova Vascular's Laguna Thrombectomy System for treating venous thromboembolism.
The Laguna Thrombectomy System consists of the Malibu Aspiration Catheter System and the Laguna Clot Retriever System, which are designed to optimize clot extraction procedures in challenging cases, Varian said. The system features a simplified setup process, flexibility and trackability, and a comprehensive range of sizes, according to the company.
Bulent Arslan, MD, professor and chair of vascular and interventional services at Rush University Medical Center, will ...
Source: AuntMinnie.com Headlines - May 15, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Acute ischaemic stroke and deep vein thrombosis following snakebite - Das DS, Mohapatra RK, Mohanty RR, Patel RK.
Snakebite envenomation remains a neglected tropical public health issue claiming thousands of lives every year. It is a common medical emergency and a threat to the impoverished populations of low-income and middle-income countries including India. A combi... (Source: SafetyLit)
Source: SafetyLit - May 10, 2024 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news
Bariatric Surgery Tied to Higher Short-Term Risk for Venous Thromboembolism
THURSDAY, May 9, 2024 -- In the short term, bariatric surgery is associated with a greater risk for venous thromboembolism (VTE), but in the long-term, it is associated with lower risk, according to a study published online April 30 in Obesity... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2024 Category: Pharmaceuticals Source Type: news
ISMRM: Young investigators study white matter hemodynamics, carotid webs, and more
This study addressed unmet need for a cross-vendor, multiparametric technique to facilitate data pooling across sites. Intrascanner repeatability and intervendor reproducibility were evaluated in vivo on five different 3-tesla (3T) systems from four vendors (GE HealthCare, Philips, Siemens Healthineers, and Canon Medical Systems). Fujita and colleagues evaluated a vendor-standardized multiparametric mapping scheme based on 3D-QALAS for whole-brain T1, T2, and proton density (PD) mapping. 3D-QALAS provided T1, T2, and PD with coefficient of variations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2024 Category: Radiology Authors: Liz Carey Tags: Head and Neck Radiology Neuroradiology ISMRM 2024 Source Type: news
Every vaccine carries a risk. If benefits outweigh it, you use it: Dr Shahid Jameel
It said there was a very rare chance of something called TTS. TTS is thrombosis and thrombocytopenia syndrome. Thrombosis means blood clots, thrombocytopenia means a reduction in the level of platelets. Platelets prevent bleeding so people who have low platelets bleed at the slightest provocation and this bleeding leads to internal clotting. A dengue virus infection can also cause thrombocytopenia. So they have admitted to a very rare event. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 4, 2024 Category: Pharmaceuticals Source Type: news
Clot in blood vessels occurs in rare cases with certain vaccines: Medical Expert amid reports over AstraZeneca
Dr. Rajeev Jayadevan, Co-Chairman of the National Indian Medical Association (IMA) Covid Task Force in Kerala, explains that Thrombosis Thrombocytopenia Syndrome (TTS), involving blood clots in rare cases, has been associated with certain vaccines, including adenovirus vector vaccines like Covishield. Despite the rarity, such events have been highlighted in reports, amidst recent admission by AstraZeneca regarding TTS risks. The WHO has also issued guidance on managing TTS cases following COVID-19 vaccination. (Source: The Economic Times)
Source: The Economic Times - May 2, 2024 Category: Consumer Health News Source Type: news
AstraZeneca acknowledges risky side effects: What are the symptoms you shouldn't ignore
AstraZeneca's admission of Covishield's potential link to Thrombosis with Thrombocytopenia Syndrome (TTS) has stirred concerns. Despite its rarity, social media debates over vaccine safety persist. Covishield, similar to AstraZeneca's, faces scrutiny, though TTS isn't exclusive to them. Here are all the answers about your doubts related to the recent controversy over AstraZeneca's Covishield. (Source: The Economic Times)
Source: The Economic Times - May 2, 2024 Category: Consumer Health News Source Type: news
Took AstraZeneca's Covishield? Should I be worried? What are the risky side effects I shouldn't ignore? Here are all the answers
AstraZeneca's admission of Covishield's potential link to Thrombosis with Thrombocytopenia Syndrome (TTS) has stirred concerns. Despite its rarity, social media debates over vaccine safety persist. Covishield, similar to AstraZeneca's, faces scrutiny, though TTS isn't exclusive to them. Here are all the answers about your doubts related to the recent controversy over AstraZeneca's Covishield. (Source: The Economic Times)
Source: The Economic Times - May 2, 2024 Category: Consumer Health News Source Type: news
Concerns raised over Covishield vaccine safety in India's apex court
A plea has been filed seeking setting up of an expert medical panel to study and assess the possible risk factors associated with the Astrazeneca's Covishield vaccine, which was one of two vaccines administered in India against Covid-19. Advocate Vishal Tiwari in his fresh application said that AstraZeneca had accepted a link between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 1, 2024 Category: Pharmaceuticals Source Type: news
Amid Covishield row, what WHO says on side-effects from Covid vaccine? Should you be worried?
Recent revelations by pharmaceutical company AstraZeneca have brought Covid vaccines back into the spotlight, with acknowledgment that its AstraZeneca-Oxford vaccine can, in very rare instances, lead to Thrombosis Thrombocytopenia Syndrome (TTS)," a condition involving the formation of blood clots in blood vessels. Despite these rare occurrences, the pharmaceutical firm maintains that extensive clinical trial data and real-world evidence consistently support the safety and effectiveness of the vaccine. (Source: The Economic Times)
Source: The Economic Times - May 1, 2024 Category: Consumer Health News Source Type: news
What WHO says on side-effects from Covid vaccine? Should you be worried?
Recent revelations by pharmaceutical company AstraZeneca have brought Covid vaccines back into the spotlight, with acknowledgment that its AstraZeneca-Oxford vaccine can, in very rare instances, lead to Thrombosis Thrombocytopenia Syndrome (TTS)," a condition involving the formation of blood clots in blood vessels. Despite these rare occurrences, the pharmaceutical firm maintains that extensive clinical trial data and real-world evidence consistently support the safety and effectiveness of the vaccine. (Source: The Economic Times)
Source: The Economic Times - May 1, 2024 Category: Consumer Health News Source Type: news
Covishield Vaccine: Bereaved parents to take Serum Institute of India to Court following AstraZeneca's rare side effect admission
Covishield Vaccine Case: The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over allegations that its vaccine, developed with the University of Oxford, led to deaths and serious injuries, including thrombosis with thrombocytopenia syndrome (TTS), characterized by blood clots and low platelet count. (Source: The Economic Times Heal...
Source: The Economic Times Healthcare and Biotech News - April 30, 2024 Category: Pharmaceuticals Source Type: news
Covishield Case: Bereaved parents to take Serum Institute of India to Court following AstraZeneca's rare side effect admission
The parents of a woman allegedly deceased after receiving the Covishield vaccine plan to file a case against the Serum Institute of India (SII). This decision follows AstraZeneca's acknowledgment in court that their Covid shot can cause a rare side effect, providing hope for the parents in seeking justice. AstraZeneca faces a class-action lawsuit over allegations that its vaccine, developed with the University of Oxford, led to deaths and serious injuries, including thrombosis with thrombocytopenia syndrome (TTS), characterized by blood clots and low platelet count. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 30, 2024 Category: Pharmaceuticals Source Type: news
Reasons for Heightened Thrombotic Risk in RA Remain Unclear Reasons for Heightened Thrombotic Risk in RA Remain Unclear
Irrespective of age, duration of disease, and other factors, people with rheumatoid arthritis have a consistently higher risk for venous thromboembolism than the general population.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 30, 2024 Category: Consumer Health News Tags: Rheumatology News Source Type: news
